Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Collegium Pharmaceutical (COLL) Receivables - Net (2016 - 2025)

Collegium Pharmaceutical has reported Receivables - Net over the past 10 years, most recently at $211.3 million for Q4 2025.

  • Quarterly results put Receivables - Net at $211.3 million for Q4 2025, down 7.53% from a year ago — trailing twelve months through Dec 2025 was $211.3 million (down 7.53% YoY), and the annual figure for FY2025 was $211.3 million, down 7.53%.
  • Receivables - Net for Q4 2025 was $211.3 million at Collegium Pharmaceutical, down from $233.9 million in the prior quarter.
  • Over the last five years, Receivables - Net for COLL hit a ceiling of $233.9 million in Q3 2025 and a floor of $90.1 million in Q2 2021.
  • Median Receivables - Net over the past 5 years was $182.5 million (2022), compared with a mean of $179.6 million.
  • Biggest five-year swings in Receivables - Net: skyrocketed 119.21% in 2022 and later fell 15.2% in 2023.
  • Collegium Pharmaceutical's Receivables - Net stood at $105.8 million in 2021, then soared by 73.01% to $183.1 million in 2022, then fell by 1.96% to $179.5 million in 2023, then increased by 27.3% to $228.5 million in 2024, then decreased by 7.53% to $211.3 million in 2025.
  • The last three reported values for Receivables - Net were $211.3 million (Q4 2025), $233.9 million (Q3 2025), and $213.0 million (Q2 2025) per Business Quant data.